Volume 13, Number 10—October 2007
Dispatch
Multidrug-Resistant Salmonella Typhimurium, Pacific Northwest, United States
Table 1
Resistance characteristics† | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 |
---|---|---|---|---|---|---|
TYP035 | ||||||
ASu | 1 | 1 | 1 | |||
ACaz | 1 | |||||
AKSuT | 1 | 1 | ||||
AKSSuT | 7 | 7 | 1 | 4 | 1 | 4 |
ACKSSuT | 1 | 1 | ||||
AKSSuTCaz | 3 | |||||
AKSxtSSuT | 1 | |||||
ACKSSuTCaz | 2 | 2 | ||||
ACKSxtSSuT | 1 | |||||
AKSuTCaz | 1 | |||||
AKSSuTCaz | 1 | 1 | ||||
ACKSSuTCaz | 2 | 1 | ||||
ACKSxtSSuTCaz | 1 | 1 | 6 | 4 | ||
AGKSxtSSuTCaz |
1 |
|||||
Total |
8 |
10 |
5 |
17 |
12 |
8 |
TYP187 | ||||||
ACSSuTCaz | 1 | |||||
AKSSuTCaz | 1 | 12 | ||||
AKSuTCaz |
1 |
|||||
Total | 1 | 2 | 12 |
*PFGE, pulsed-field gel electrophoresis.
†A, ampicillin; Su, triple-sulfa; Caz, ceftazidime; K, kanamycin; T, tetracycline; S, streptomycin; C, chloramphenicol; Sxt, trimethoprim-sulfamethoxazole; G, gentamicin. In April 2005 nitrofurantoin, trimethoprim, and ciprofloxacin were dropped from the panel, and amoxicillin-clavulanic acid, nalidixic acid, and ceftazidime-clavulanic acid were added.
Page created: July 02, 2010
Page updated: July 02, 2010
Page reviewed: July 02, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.